½ÃÀ庸°í¼­
»óǰÄÚµå
1609835

ÀϺ»ÀÇ ¿©¼º °Ç°­ ½ÃÀå º¸°í¼­ : ¿¬·ÉÃþ À¯Çü, ¿ëµµ, À¯Åë ä³Î, Áö¿ªº°(2024-2032³â)

Japan Women¢¥s Health Market Report by Age Group Type, Application, Distribution Channel, and Region 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 119 Pages | ¹è¼Û¾È³» : 5-7ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÀϺ»ÀÇ ¿©¼º °Ç°­ ½ÃÀåÀÇ ½ÃÀå ±Ô¸ð´Â 2023³â¿¡ 24¾ï 1,900¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº ½ÃÀåÀÌ 2032³â±îÁö 32¾ï 7,800¸¸ ´Þ·¯¿¡ ´ÞÇϸç, 2024-2032³â 3.4%ÀÇ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ·Îº¿ Áö¿ø ¼ö¼ú, Àúħ½À¼ö¼ú, ¿ø°ÝÀÇ·á µî ÀÇ·á ±â¼úÀÇ Áøº¸°¡ ÁøÇàµÇ¸ç, ¿©¼º °Ç°­ »óÅÂÀÇ Áø´ÜÀ̳ª Ä¡·á ¿É¼ÇÀÌ Áõ°¡ÇÑ °ÍÀÌ ÁÖ·Î ½ÃÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

º» ¸®Æ÷Æ®¿¡¼­ ´äº¯ÇÏ´Â ÁÖ¿ä Áú¹®

  • ÀϺ»ÀÇ ¿©¼º °Ç°­ ½ÃÀåÀº Áö±Ý±îÁö ¾î¶»°Ô ÃßÀÌÇØ ¿ÔÀ¸¸ç, ÇâÈÄ ¾î¶»°Ô ÃßÀÌÇϴ°¡?
  • COVID-19°¡ ÀϺ»ÀÇ ¿©¼º °Ç°­ ½ÃÀå¿¡ ¹ÌÄ£ ¿µÇâÀº?
  • ÀϺ»ÀÇ ¿©¼º °Ç°­ ½ÃÀåÀÇ ¿¬·ÉÃþº° ³»¿ªÀº?
  • ÀϺ»ÀÇ ¿©¼º °Ç°­ ½ÃÀåÀÇ ¿ëµµº° ³»¿ªÀº?
  • ÀϺ»ÀÇ ¿©¼º °Ç°­ ½ÃÀåÀÇ À¯Åë ä³Îº° ³»¿ªÀº?
  • ÀϺ»ÀÇ ¿©¼º °Ç°­ ½ÃÀåÀÇ ¹ë·ùüÀο¡´Â ¾î¶² ´Ü°è°¡ Àִ°¡?
  • ÀϺ»ÀÇ ¿©¼º °Ç°­¿¡ °üÇÑ ÁÖ¿ä ÃËÁø¿äÀΰú °úÁ¦´Â ¹«¾ùÀΰ¡?
  • ÀϺ»ÀÇ ¿©¼º °Ç°­ ½ÃÀåÀÇ ±¸Á¶¿Í ÁÖ¿ä ±â¾÷Àº?
  • ÀϺ»ÀÇ ¿©¼º °Ç°­ ½ÃÀå¿¡¼­ °æÀïÀÇ Á¤µµ´Â?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»çÀÇ ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
  • ½ÃÀå ÃßÁ¤
  • Á¶»ç ¹æ¹ý

Á¦3Àå °³¿ä

Á¦4Àå ÀϺ»ÀÇ ¿©¼º °Ç°­ ½ÃÀå : ¼­·Ð

  • °³¿ä
  • ½ÃÀå ¿ªÇÐ
  • ¾÷°è µ¿Çâ
  • °æÀï Á¤º¸

Á¦5Àå ÀϺ»ÀÇ ¿©¼º °Ç°­ ½ÃÀå ±¸µµ

  • °ú°Å ¹× ÇöÀç ½ÃÀå µ¿Çâ(2018-2023³â)
  • ½ÃÀå ¿¹Ãø(2024-2032³â)

Á¦6Àå ÀϺ»ÀÇ ¿©¼º °Ç°­ ½ÃÀå : ¿¬·ÉÃþ À¯Çüº° ³»¿ª

  • 50¼¼ ÀÌ»ó
  • ±âŸ

Á¦7Àå ÀϺ»ÀÇ ¿©¼º °Ç°­ ½ÃÀå : ¿ëµµº° ³»¿ª

  • ÇÇÀÓ¾à
  • °ñ´Ù°øÁõ
  • Æó°æ
  • ºÒÀÓ
  • ±âŸ

Á¦8Àå ÀϺ»ÀÇ ¿©¼º °Ç°­ ½ÃÀå : À¯Åë ä³Îº° ³»¿ª

  • º´¿ø ¾à±¹
  • ¼Ò¸Å ¾à±¹
  • ¿Â¶óÀÎ ¾à±¹

Á¦9Àå ÀϺ»ÀÇ ¿©¼º °Ç°­ ½ÃÀå : °æÀï ±¸µµ

  • °³¿ä
  • ½ÃÀå ±¸Á¶
  • ½ÃÀå ±â¾÷ Æ÷Áö¼Å´×
  • ÁÖ¿ä ¼º°ø Àü·«
  • °æÀï ´ë½Ãº¸µå
  • ±â¾÷ Æò°¡ »óÇÑ

Á¦10Àå ÁÖ¿ä ±â¾÷ÀÇ °³¿ä

Á¦11Àå ÀϺ»ÀÇ ¿©¼º °Ç°­ ½ÃÀå : ¾÷°è ºÐ¼®

  • ÃËÁø¿äÀΡ¤¾ïÁ¦¿äÀΡ¤±âȸ
  • Porter's Five Forces ºÐ¼®
  • ¹ë·ùüÀÎ ºÐ¼®

Á¦12Àå ºÎ·Ï

KSA 24.12.24

Japan women's health market size reached US$ 2,419.0 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 3,278.0 Million by 2032, exhibiting a growth rate (CAGR) of 3.4% during 2024-2032. The increasing advances in medical technology, such as robotic-assisted surgery, minimally invasive procedures, and telemedicine, which have improved the diagnosis and treatment options available for women's health conditions, are primarily driving the market.

Women's health refers to the unique physical, mental, and emotional well-being of women across their lifespan. It encompasses a wide range of issues, including reproductive health, sexual health, and overall physical fitness. Key aspects of women's health include menstrual and menopausal health, pregnancy and childbirth, contraception, breast health, and gynecological care. Regular check-ups, screenings, and access to healthcare are essential to maintaining women's health. This includes Pap smears, mammograms, and discussions about family planning. Mental health is also crucial, as women are more susceptible to conditions like depression and anxiety. A healthy lifestyle, including a balanced diet, regular exercise, and stress management, plays a significant role in women's health. Additionally, promoting gender equality and addressing societal factors that affect women's health, such as discrimination and unequal access to healthcare, are essential steps toward ensuring that women can lead healthy and fulfilling lives. Women's health is a multifaceted and critical aspect of public health, deserving attention and support.

Japan Women's Health Market Trends:

The women's health market in Japan is multifaceted and interconnected, driven by various factors that collectively shape the landscape of healthcare for women. Firstly, advances in medical research and technology have significantly propelled the women's health market forward. Breakthroughs in diagnostic tools, such as mammography and genetic testing, have enhanced the early detection of diseases like breast cancer and hereditary conditions, improving overall health outcomes. Secondly, the growing awareness of women's unique healthcare needs has played a pivotal role. Women are increasingly informed about the importance of preventive care, leading to higher demand for gynecological services, contraceptives, and maternity care. Furthermore, societal shifts, including delayed childbirth and an aging female population, have contributed to the expansion of this market. These shifts require tailored healthcare solutions, driving innovation and investment in women's health services. Moreover, various regulatory changes and government initiatives improve access to healthcare through several policies, thereby enhancing the affordability and availability of women's health services. This, in turn, is expected to drive the women's health market in Japan during the forecast period.

Japan Women's Health Market Segmentation:

Age Group Type Insights:

50 Years and Above

  • Postmenopausal Osteoporosis
  • Endometriosis and Uterine Fibroids
  • Menopause
  • Others

Application Insights:

  • Contraceptives
  • Osteoporosis
  • Menopause
  • Infertility
  • Others

Distribution Channel Insights:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan women's health market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan women's health market?
  • What is the breakup of the Japan women's health market on the basis of age group type?
  • What is the breakup of the Japan women's health market on the basis of application?
  • What is the breakup of the Japan women's health market on the basis of distribution channel?
  • What are the various stages in the value chain of the Japan women's health market?
  • What are the key driving factors and challenges in the Japan women's health?
  • What is the structure of the Japan women's health market and who are the key players?
  • What is the degree of competition in the Japan women's health market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Women's Health Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Women's Health Market Landscape

  • 5.1 Historical and Current Market Trends (2018-2023)
  • 5.2 Market Forecast (2024-2032)

6 Japan Women's Health Market - Breakup by Age Group Type

  • 6.1 50 Years and Above
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2018-2023)
    • 6.1.3 Market Segmentation
      • 6.1.3.1 Postmenopausal Osteoporosis
      • 6.1.3.2 Endometriosis and Uterine Fibroids
      • 6.1.3.3 Menopause
    • 6.1.4 Market Forecast (2024-2032)
  • 6.2 Others
    • 6.2.1 Historical and Current Market Trends (2018-2023)
    • 6.2.2 Market Forecast (2024-2032)

7 Japan Women's Health Market - Breakup by Application

  • 7.1 Contraceptives
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2018-2023)
    • 7.1.3 Market Forecast (2024-2032)
  • 7.2 Osteoporosis
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2018-2023)
    • 7.2.3 Market Forecast (2024-2032)
  • 7.3 Menopause
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2018-2023)
    • 7.3.3 Market Forecast (2024-2032)
  • 7.4 Infertility
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2018-2023)
    • 7.4.3 Market Forecast (2024-2032)
  • 7.5 Others
    • 7.5.1 Historical and Current Market Trends (2018-2023)
    • 7.5.2 Market Forecast (2024-2032)

8 Japan Women's Health Market - Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2018-2023)
    • 8.1.3 Market Forecast (2024-2032)
  • 8.2 Retail Pharmacies
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2018-2023)
    • 8.2.3 Market Forecast (2024-2032)
  • 8.3 Online Pharmacies
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2018-2023)
    • 8.3.3 Market Forecast (2024-2032)

9 Japan Women's Health Market - Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Company A
    • 10.1.1 Business Overview
    • 10.1.2 Product Portfolio
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Company B
    • 10.2.1 Business Overview
    • 10.2.2 Product Portfolio
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Company C
    • 10.3.1 Business Overview
    • 10.3.2 Product Portfolio
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Company D
    • 10.4.1 Business Overview
    • 10.4.2 Product Portfolio
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Company E
    • 10.5.1 Business Overview
    • 10.5.2 Product Portfolio
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

11 Japan Women's Health Market - Industry Analysis

  • 11.1 Drivers, Restraints, and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦